LineaBio Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
LineaBio General Information
Description
Manufacturer of drug products intended to serve the cell and gene therapy industry. The company specializes in both unmodified iPSC lines and iPSC lines modified with gene editing tools to enhance the utility of therapeutic cells, thereby enabling therapeutic developers to cut costs and accelerate timelines to GMP.
Contact Information
Website
www.lineabio.comCorporate Office
- MaRS Centre, West Tower
- 661 University Avenue, Suite 1002
- Toronto, Ontario M5G 1M1
- Canada
Corporate Office
- MaRS Centre, West Tower
- 661 University Avenue, Suite 1002
- Toronto, Ontario M5G 1M1
- Canada
LineaBio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LineaBio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LineaBio FAQs
-
When was LineaBio founded?
LineaBio was founded in 2023.
-
Where is LineaBio headquartered?
LineaBio is headquartered in Toronto, Canada.
-
What industry is LineaBio in?
LineaBio’s primary industry is Drug Discovery.
-
Is LineaBio a private or public company?
LineaBio is a Private company.
-
What is LineaBio’s current revenue?
The current revenue for LineaBio is .
-
Who are LineaBio’s investors?
Centre for Commercialization of Regenerative Medicine and OmniaBio have invested in LineaBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process